The U.S. Preventive Services Task Force released a recommendation this week calling on health care providers to prescribe all approved PrEP options for people at increased risk for HIV.
A study on almost four thousand people of African descent has identified a gene that acts as natural defense against HIV by limiting its replication in certain white blood cells. An international effort co-led by EPFL, Canada’s National Microbiology Laboratory, and Imperial College London, it paves the way for new treatment strategies and underscores the importance of studying diverse ancestral populations to better address their specific medical needs and global health disparities.
The recent Conference on Retroviruses and Opportunistic Infections featured the work of San Francisco experts, including studies of long-acting injectable HIV treatment and antibiotics to prevent sexually transmitted infections.
The recent Conference on Retroviruses and Opportunistic Infections featured the work of San Francisco experts, including studies of long-acting injectable HIV treatment and antibiotics to prevent sexually transmitted infections.
The recent Conference on Retroviruses and Opportunistic Infections featured the work of San Francisco experts, including studies of long-acting injectable HIV treatment and antibiotics to prevent sexually transmitted infections.